Literature DB >> 3443068

Haemodynamic effects of felodipine in congestive heart failure.

P Held1, K Swedberg.   

Abstract

The acute and long term central haemodynamic effects of felodipine were studied in 9 patients with severe congestive heart failure (NYHA III-IV). A felodipine dose of 5 to 15 mg tid was individually titrated during a 24 to 48 hour catheterisation period. One patient received 5mg tid, 5 patients 10mg tid and 3 patients 15 mg tid. At rest the individual maximal dose was associated with a significant fall in systolic and diastolic blood pressure, pulmonary artery diastolic pressure, heart rate and systemic vascular resistance, while stroke volume was significantly increased. During upright submaximal (30-50 watts) bicycle exercise, the changes were principally the same with the addition of a significant increase of cardiac index. Six patients were re-evaluated after 30 days of continuous treatment. Their resting haemodynamics had returned to the control level but during exercise the significant changes in cardiac index, stroke volume and vascular resistance persisted. The results indicated a beneficial effect of felodipine in the treatment of heart failure, but further studies are needed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3443068     DOI: 10.2165/00003495-198700343-00018

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  11 in total

1.  Electrophysiological effects of felodipine.

Authors:  M Been; P W Macfarlane; W S Hillis
Journal:  Drugs       Date:  1985       Impact factor: 9.546

2.  Short- and long-term efficacy of a calcium-antagonistic agent (nifedipine) combined with methyldopa in the treatment of severe hypertension.

Authors:  M D Guazzi; C Fiorentini; M T Olivari; A Bartorelli; G Necchi; A Polese
Journal:  Circulation       Date:  1980-05       Impact factor: 29.690

3.  Haemodynamic effects of nifedipine in heart failure.

Authors:  S Klugmann; A Salvi; F Camerini
Journal:  Br Heart J       Date:  1980-04

4.  Role of vasodilators in the treatment of congestive heart failure.

Authors:  T B Levine
Journal:  Am J Cardiol       Date:  1985-01-11       Impact factor: 2.778

5.  Effects of vasodilator treatment with felodipine on haemodynamic responses to treadmill exercise in congestive heart failure.

Authors:  A D Timmis; P Smyth; J F Kenny; S Campbell; D E Jewitt
Journal:  Br Heart J       Date:  1984-09

6.  Beneficial hemodynamic effects of intravenous and oral diltiazem in severe congestive heart failure.

Authors:  R W Walsh; C B Porter; M R Starling; R A O'Rourke
Journal:  J Am Coll Cardiol       Date:  1984-04       Impact factor: 24.094

7.  Acute haemodynamic and metabolic effects of felodipine in congestive heart failure.

Authors:  A D Timmis; S Campbell; M J Monaghan; L Walker; D E Jewitt
Journal:  Br Heart J       Date:  1984-04

8.  Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow.

Authors:  C V Leier; T J Patrick; J Hermiller; K D Pacht; P Huss; R D Magorien; D V Unverferth
Journal:  Am Heart J       Date:  1984-12       Impact factor: 4.749

9.  Vascular selectivity of felodipine.

Authors:  B Ljung
Journal:  Drugs       Date:  1985       Impact factor: 9.546

10.  Acute haemodynamic effects of felodipine during beta blockade in patients with coronary artery disease.

Authors:  W Culling; M S Ruttley; D J Sheridan
Journal:  Br Heart J       Date:  1984-10
View more
  2 in total

Review 1.  Calcium antagonists in patients with heart failure. A review.

Authors:  H Reicher-Reiss; E Barasch
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

Review 2.  Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  E Saltiel; A G Ellrodt; J P Monk; M S Langley
Journal:  Drugs       Date:  1988-10       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.